| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,137 | 10,620 | 8,813 | 13,535 | | Cost of Revenue | 5,081 | 5,321 | 4,989 | 6,382 | | | Gross Profit | 6,056 | 5,299 | 3,824 | 7,153 | | | Operating Expenses | | Research Development | 438 | 543 | 1,851 | 775 | | Selling General and Administrative | 4,721 | 4,575 | 5,894 | 5,646 | | Non Recurring | 675 |
-
| (348) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 222 | 181 | (3,573) | 732 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (50) | (9) | (116) | (11) | | Earnings Before Interest And Taxes | 165 | 172 | (3,689) | 721 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 165 | 172 | (3,689) | 721 | | Income Tax Expense | 25 | 49 | 2,776 | (10) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 140 | 123 | (6,465) | 731 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 140 | 123 | (6,465) | 731 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $140 | $123 | ($6,465) | $731 |
|
0.51% Nasdaq 
Income Statement
